Analysis of the Clinical Efficacy of TACE Combined with PD-1 Inhibitors and/or TKI Multimodal Treatment of Hepatocellular Carcinoma

Advances in Clinical Medicine 2026

View at publisher

Authors: 汗色

DOI: 10.12677/acm.2026.163866

Cited by: 0

References: 3

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Cancer Immunotherapy and Biomarkers Renal cell carcinoma treatment

References 3